Trial Profile
Multicenter, randomized, double-blind, placebo controlled trial of 2 mg melatonin for circadian phase adjustment and improvement of metabolic control in night shift workers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Apr 2017
Price :
$35
*
At a glance
- Drugs Melatonin (Primary)
- Indications Shift work insomnia
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- 19 Apr 2017 Status changed from recruiting to completed.
- 03 Mar 2014 New trial record